United Therapeutics
Price & Volume
Stats
See moreOpen | $525.57 |
Previous Close | $529.66 |
Day Range | $516.37-$533.06 |
52W Range | $292.34-$609.35 |
Market Cap | $22.7B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $3.1B |
Revenue Growth (YoY) | -1.9% |
Gross Profit (12 Mos) | $2.7B |
Diluted EPS | $27.92 |
News
See moreYahoo Finance • 5 days ago
United Therapeutics' Q2 Tyvaso Miss Reflects Competition; IPF Outreach Set to Expand, Morgan Stanley Says
Yahoo Finance • 16 days ago
PINK vs. XLV: How Do These Two Health Care ETFs Match Up?
Yahoo Finance • 18 days ago
United Therapeutics Appoints Victor Dzau To Board Of Directors
Yahoo Finance • 20 days ago
Liquidia jumps as judge criticizes United Therapeutics in patent dispute
About
CEO | Dr. Martine A. Rothblatt J.D., M.B.A., Ph.D. |
CFO | Mr. James C. Edgemond |
Address | 1000 Spring Street, Silver Spring, MD, United States, 20910 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 1,400 |